Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Cytokinetics granted inducement stock options on 60,465 shares and RSUs on 40,084 shares to 29 new hires under Nasdaq Listing Rule 5635(c)(4). Options carry a $63.92 exercise price, equal to the October 15, 2026 close, and vest over four years; RSUs vest over three years on a 40/40/20 schedule.
Key figures
- Employees granted
- 29
- Rsu granted units
- 40084
- Option exercise price
- 63.92
- Options granted shares
- 60465
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.